Panitumumab trials for Pancreatic cancer

All Panitumumab trials · All Pancreatic cancer trials

Phase breakdown

Recruiting trials studying Panitumumab for Pancreatic cancer

• A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
  NCT07094204 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 20 locations
• AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
  NCT07094113 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 39 locations
• Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
  NCT03384238 · Phase: Phase 1, Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
  NCT06998940 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 274 locations

Common questions

How many trials study Panitumumab for Pancreatic cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.